<DOC>
	<DOCNO>NCT01200225</DOCNO>
	<brief_summary>This prospective observational study assess insulin resistance impact sustain virological response patient hepatitis C treat Pegasys Copegus . Data collect patient 72 week treatment 24 week treatment-free follow-up .</brief_summary>
	<brief_title>An Observational Study The Impact Insulin Resistance Sustained Virological Response Patients With Hepatitis C Treated With Pegasys ( Peginterferon Alfa-2a ) Copegus ( Ribavirin )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Chronic hepatitis C ( detectable HCV RNA ) Initiation treatment Pegasys Copegus Participation clinical trial study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>